Ekso Bionics Holdings Q2 EPS $(0.31) Misses $(0.28) Estimate, Sales $4.70M Beat $4.35M Estimate
Portfolio Pulse from Benzinga Newsdesk
Ekso Bionics Holdings reported Q2 losses of $(0.31) per share, missing the analyst consensus estimate of $(0.28) by 10.71%. However, the company's quarterly sales of $4.70 million beat the analyst consensus estimate of $4.35 million by 8.11%. This represents a 35.73% increase over sales from the same period last year.
July 27, 2023 | 8:43 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Ekso Bionics reported a larger than expected loss for Q2 but beat sales estimates. This mixed report may lead to uncertainty in the market.
The company reported a larger than expected loss, which is negative for the stock. However, it also reported higher than expected sales, which is positive. The net effect on the stock is uncertain.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100